TETRAHYDROZOLINE HCL

N/A

Manufactured by Chain Drug Marketing Assoc., Inc.

76 FDA adverse event reports analyzed

Last updated: 2026-04-15

About TETRAHYDROZOLINE HCL

TETRAHYDROZOLINE HCL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Chain Drug Marketing Assoc., Inc.. The most commonly reported adverse reactions for TETRAHYDROZOLINE HCL include FATIGUE, ALANINE AMINOTRANSFERASE INCREASED, ASPARTATE AMINOTRANSFERASE INCREASED, ASTHENIA, BLOOD ALKALINE PHOSPHATASE INCREASED. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for TETRAHYDROZOLINE HCL.

Top Adverse Reactions

FATIGUE3 reports
ALANINE AMINOTRANSFERASE INCREASED2 reports
ASPARTATE AMINOTRANSFERASE INCREASED2 reports
ASTHENIA2 reports
BLOOD ALKALINE PHOSPHATASE INCREASED2 reports
DYSGEUSIA2 reports
FALL2 reports
GRAFT VERSUS HOST DISEASE2 reports
NEUTROPHIL COUNT DECREASED2 reports
OEDEMA PERIPHERAL2 reports
PYREXIA2 reports
ABDOMINAL DISCOMFORT1 reports
ABDOMINAL DISTENSION1 reports
ACCIDENTAL EXPOSURE TO PRODUCT1 reports
ALOPECIA1 reports
ARTHRITIS1 reports
BLEPHARITIS1 reports
BLOOD CREATININE INCREASED1 reports
CANDIDA INFECTION1 reports
CARDIAC FAILURE1 reports
CARDIAC FAILURE CONGESTIVE1 reports
CHILLS1 reports
CONFUSIONAL STATE1 reports
DEATH1 reports
DECREASED APPETITE1 reports
DELUSION1 reports
DEPRESSED MOOD1 reports
DIARRHOEA1 reports
DYSSTASIA1 reports
GAIT DISTURBANCE1 reports
GASTROENTERITIS1 reports
HALLUCINATION1 reports
HEAD INJURY1 reports
HYPERSOMNIA1 reports
INCREASED TENDENCY TO BRUISE1 reports
INFLUENZA1 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES1 reports
MEMORY IMPAIRMENT1 reports
MOBILITY DECREASED1 reports
MUSCULAR WEAKNESS1 reports
MUSCULOSKELETAL PAIN1 reports
MUSCULOSKELETAL STIFFNESS1 reports
NECK PAIN1 reports
NERVE DEGENERATION1 reports
NEURALGIA1 reports
OFF LABEL USE1 reports
ONYCHOCLASIS1 reports
PANCYTOPENIA1 reports
PARKINSON^S DISEASE1 reports
PNEUMONIA1 reports
POISONING DELIBERATE1 reports
PRURITUS1 reports
PULMONARY EMBOLISM1 reports
RADICULOPATHY1 reports
RASH1 reports
RENAL IMPAIRMENT1 reports
RIB FRACTURE1 reports
SKIN LACERATION1 reports
STOMATITIS1 reports
TEMPERATURE INTOLERANCE1 reports
UNRESPONSIVE TO STIMULI1 reports
URINARY TRACT INFECTION1 reports
VULVOVAGINAL BURNING SENSATION1 reports
VULVOVAGINAL PAIN1 reports

Report Outcomes

Out of 13 classified reports for TETRAHYDROZOLINE HCL:

Serious 84.6%Non-Serious 15.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male7 (53.8%)
Female6 (46.2%)

Reports by Age

Age 512 reports
Age 301 reports
Age 561 reports
Age 641 reports
Age 661 reports
Age 691 reports
Age 701 reports
Age 711 reports
Age 821 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with TETRAHYDROZOLINE HCL?

This profile reflects 76 FDA FAERS reports that mention TETRAHYDROZOLINE HCL. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for TETRAHYDROZOLINE HCL?

Frequently reported terms in FAERS include FATIGUE, ALANINE AMINOTRANSFERASE INCREASED, ASPARTATE AMINOTRANSFERASE INCREASED, ASTHENIA, BLOOD ALKALINE PHOSPHATASE INCREASED, DYSGEUSIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures TETRAHYDROZOLINE HCL?

Labeling and FAERS entries often list Chain Drug Marketing Assoc., Inc. in connection with TETRAHYDROZOLINE HCL. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.